Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

Authors: Hussein A. Tawbi, Dirk Schadendorf, Evan J. Lipson, Paolo A. Ascierto, Luis Matamala et al.

Year: 2022

NivolumabMedicineOncologyInternal medicineMetastatic melanoma